| Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer N Hanna, PA Bunn Jr, C Langer, L Einhorn, T Guthrie Jr, T Beck, R Ansari, ... Journal of clinical oncology 24 (13), 2038-2043, 2006 | 820 | 2006 |
| Communicating with realism and hope: incurable cancer patients' views on the disclosure of prognosis RG Hagerty, PN Butow, PM Ellis, EA Lobb, SC Pendlebury, N Leighl, ... Journal of clinical oncology 23 (6), 1278-1288, 2005 | 724 | 2005 |
| Systemic therapy for stage IV non–small-cell lung cancer: American Society of Clinical Oncology clinical practice guideline update N Hanna, D Johnson, S Temin, S Baker Jr, J Brahmer, PM Ellis, ... Journal of Clinical Oncology 35 (30), 3484-3515, 2017 | 676 | 2017 |
| Communicating prognosis in cancer care: a systematic review of the literature RG Hagerty, PN Butow, PM Ellis, S Dimitry, MHN Tattersall Annals of oncology 16 (7), 1005-1053, 2005 | 603 | 2005 |
| Cancer patient preferences for communication of prognosis in the metastatic setting RG Hagerty, PN Butow, PA Ellis, EA Lobb, S Pendlebury, N Leighl, ... Journal of clinical oncology 22 (9), 1721-1730, 2004 | 579 | 2004 |
| Barriers to participation in clinical trials of cancer: a meta-analysis and systematic review of patient-reported factors EJ Mills, D Seely, B Rachlis, L Griffith, P Wu, K Wilson, P Ellis, JR Wright The lancet oncology 7 (2), 141-148, 2006 | 574 | 2006 |
| Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial C Butts, MA Socinski, PL Mitchell, N Thatcher, L Havel, M Krzakowski, ... The lancet oncology 15 (1), 59-68, 2014 | 560 | 2014 |
| Randomized phase IIB trial of BLP25 liposome vaccine in stage IIIB and IV non–small-cell lung cancer C Butts, N Murray, A Maksymiuk, G Goss, E Marshall, D Soulières, ... Journal of Clinical Oncology 23 (27), 6674-6681, 2005 | 556 | 2005 |
| Systemic therapy for stage IV non–small-cell lung cancer: American Society of Clinical Oncology clinical practice guideline update GA Masters, S Temin, CG Azzoli, G Giaccone, S Baker Jr, JR Brahmer, ... Journal of Clinical Oncology 33 (30), 3488-3515, 2015 | 547 | 2015 |
| On the receiving end V: patient perceptions of the side effects of cancer chemotherapy in 1993 AM Griffin, PN Butow, AS Coates, AM Childs, PM Ellis, SM Dunn, ... Annals of oncology 7 (2), 189-195, 1996 | 546 | 1996 |
| Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non–small-cell lung cancer guideline KMW Pisters, WK Evans, CG Azzoli, MG Kris, CA Smith, CE Desch, ... Journal of clinical oncology 25 (34), 5506-5518, 2007 | 453 | 2007 |
| Attitudes towards and participation in randomised clinical trials in oncology: a review of the literature PM Ellis Annals of Oncology 11 (8), 939-946, 2000 | 340 | 2000 |
| Adjuvant systemic therapy and adjuvant radiation therapy for stage I to IIIA completely resected non–small-cell lung cancers: American Society of Clinical Oncology/Cancer Care … MG Kris, LE Gaspar, JE Chaft, EB Kennedy, CG Azzoli, PM Ellis, SH Lin, ... Journal of Clinical Oncology 35 (25), 2960-2974, 2017 | 319 | 2017 |
| Therapy for stage IV non–small-cell lung cancer without driver alterations: ASCO and OH (CCO) joint guideline update NH Hanna, BJ Schneider, S Temin, S Baker Jr, J Brahmer, PM Ellis, ... Journal of Clinical Oncology 38 (14), 1608-1632, 2020 | 298 | 2020 |
| Randomized clinical trials in oncology: understanding and attitudes predict willingness to participate PM Ellis, PN Butow, MHN Tattersall, SM Dunn, N Houssami Journal of Clinical Oncology 19 (15), 3554-3561, 2001 | 278 | 2001 |
| First-line systemic chemotherapy in the treatment of advanced non-small cell lung cancer: a systematic review J Goffin, C Lacchetti, PM Ellis, YC Ung, WK Evans Journal of Thoracic Oncology 5 (2), 260-274, 2010 | 274 | 2010 |
| Delays in the diagnosis of lung cancer PM Ellis, R Vandermeer Journal of thoracic disease 3 (3), 183, 2011 | 264 | 2011 |
| Therapy for stage IV non–small-cell lung cancer with driver alterations: ASCO and OH (CCO) joint guideline update NH Hanna, AG Robinson, S Temin, S Baker Jr, JR Brahmer, PM Ellis, ... Journal of Clinical Oncology 39 (9), 1040-1091, 2021 | 262 | 2021 |
| Randomized phase II study of gemcitabine plus cisplatin or carboplatin, with or without cetuximab, as first-line therapy for patients with advanced or metastatic non–small-cell … CA Butts, D Bodkin, EL Middleman, CW Englund, D Ellison, Y Alam, ... Journal of Clinical Oncology 25 (36), 5777-5784, 2007 | 262* | 2007 |
| Survival of patients with non-small-cell lung cancer after a diagnosis of brain metastases A Ali, JR Goffin, A Arnold, PM Ellis Current Oncology 20 (4), 300-306, 2013 | 259 | 2013 |
